These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29414910)

  • 1. Hepatoprotective Effects of a Functional Formula of Three Chinese Medicinal Herbs: Experimental Evidence and Network Pharmacology-Based Identification of Mechanism of Action and Potential Bioactive Components.
    Li S; Wang N; Hong M; Tan HY; Pan G; Feng Y
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29414910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets.
    Hong M; Li S; Wang N; Tan HY; Cheung F; Feng Y
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335383
    [No Abstract]   [Full Text] [Related]  

  • 3. Study on the effect of active components of Schisandra chinensis on liver injury and its mechanisms in mice based on network pharmacology.
    Xu G; Lv X; Feng Y; Li H; Chen C; Lin H; Li H; Wang C; Chen J; Sun J
    Eur J Pharmacol; 2021 Nov; 910():174442. PubMed ID: 34492285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Network Pharmacology-Based Study on the Hepatoprotective Effect of Fructus Schisandrae.
    Hong M; Zhang Y; Li S; Tan HY; Wang N; Mu S; Hao X; Feng Y
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28956809
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
    Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
    J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGplus, a standardized herbal composition ameliorates non-alcoholic steatohepatitis in a tunicamycin-induced mouse model.
    Lee MM; Kim HG; Lee SB; Lee JS; Kim WY; Choi SH; Lee SK; Byun CK; Hyun PM; Son CG
    Phytomedicine; 2018 Mar; 41():24-32. PubMed ID: 29519316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
    Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advance in studies on hepatoprotective effect of Salvia miltiorrhiza and its main components].
    Yuan Y; Wu Q; Shi JS; Chen XP
    Zhongguo Zhong Yao Za Zhi; 2015 Feb; 40(4):588-93. PubMed ID: 26137674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schisandra polysaccharide inhibits hepatic lipid accumulation by downregulating expression of SREBPs in NAFLD mice.
    Wang CM; Yuan RS; Zhuang WY; Sun JH; Wu JY; Li H; Chen JG
    Lipids Health Dis; 2016 Nov; 15(1):195. PubMed ID: 27852305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic metabolic profiling of urine biomarkers in rats with alcohol‑induced liver damage following treatment with Zhi‑Zi‑Da‑Huang decoction.
    An L; Lang Q; Shen W; Shi Q; Feng F
    Mol Med Rep; 2016 Sep; 14(3):2093-100. PubMed ID: 27430289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease.
    Huang S; Mu F; Li F; Wang W; Chen H; Lei L; Ma Y; Ding Y; Wang J
    J Diabetes Res; 2020; 2020():7867245. PubMed ID: 32724826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease.
    Zheng Y; Wang M; Zheng P; Tang X; Ji G
    Sci Rep; 2018 Sep; 8(1):13681. PubMed ID: 30209324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
    Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
    J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of Kangxian ruangan capsule against nonalcoholic fatty liver disease fibrosis in rats induced by MCD diet.
    Liu L; Zhou Y; Dai D; Xia H; Zhao K; Zhang J
    Biomed Pharmacother; 2018 Dec; 108():424-434. PubMed ID: 30236852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative effects of 5-hydroxymethyl-2-furfural (5-HMF) from Schisandra chinensis on alcoholic liver oxidative injury in mice.
    Li W; Qu XN; Han Y; Zheng SW; Wang J; Wang YP
    Int J Mol Sci; 2015 Jan; 16(2):2446-57. PubMed ID: 25622257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
    Jiang Y; Chen L; Wang H; Narisi B; Chen B
    J Ethnopharmacol; 2015 Dec; 176():499-507. PubMed ID: 26571089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease.
    Feng Q; Liu W; Baker SS; Li H; Chen C; Liu Q; Tang S; Guan L; Tsompana M; Kozielski R; Baker RD; Peng J; Liu P; Zhu R; Hu Y; Zhu L
    Oncotarget; 2017 Apr; 8(17):27820-27838. PubMed ID: 28416740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
    Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
    J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.